1072 related articles for article (PubMed ID: 24440671)
1. Interactions between the intestinal microbiome and liver diseases.
Schnabl B; Brenner DA
Gastroenterology; 2014 May; 146(6):1513-24. PubMed ID: 24440671
[TBL] [Abstract][Full Text] [Related]
2. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
Chen P; Torralba M; Tan J; Embree M; Zengler K; Stärkel P; van Pijkeren JP; DePew J; Loomba R; Ho SB; Bajaj JS; Mutlu EA; Keshavarzian A; Tsukamoto H; Nelson KE; Fouts DE; Schnabl B
Gastroenterology; 2015 Jan; 148(1):203-214.e16. PubMed ID: 25239591
[TBL] [Abstract][Full Text] [Related]
3. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
5. Role of gut microbiota in liver disease.
Albhaisi SAM; Bajaj JS; Sanyal AJ
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
[TBL] [Abstract][Full Text] [Related]
6. Linking intestinal homeostasis and liver disease.
Schnabl B
Curr Opin Gastroenterol; 2013 May; 29(3):264-70. PubMed ID: 23493073
[TBL] [Abstract][Full Text] [Related]
7. Host-microbiome interactions in alcoholic liver disease.
Chen P; Schnabl B
Gut Liver; 2014 May; 8(3):237-41. PubMed ID: 24827618
[TBL] [Abstract][Full Text] [Related]
8. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
9. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
Huang W; Kong D
Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
[TBL] [Abstract][Full Text] [Related]
10. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
[TBL] [Abstract][Full Text] [Related]
12. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial proteins: intestinal guards to protect against liver disease.
Hendrikx T; Schnabl B
J Gastroenterol; 2019 Mar; 54(3):209-217. PubMed ID: 30392013
[TBL] [Abstract][Full Text] [Related]
14. Obesity, fatty liver disease and intestinal microbiota.
Arslan N
World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
[TBL] [Abstract][Full Text] [Related]
15. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
16. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease.
Chu H; Duan Y; Yang L; Schnabl B
Gut; 2019 Feb; 68(2):359-370. PubMed ID: 30171065
[TBL] [Abstract][Full Text] [Related]
17. Enteric dysbiosis associated with a mouse model of alcoholic liver disease.
Yan AW; Fouts DE; Brandl J; Stärkel P; Torralba M; Schott E; Tsukamoto H; Nelson KE; Brenner DA; Schnabl B
Hepatology; 2011 Jan; 53(1):96-105. PubMed ID: 21254165
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease.
Wieland A; Frank DN; Harnke B; Bambha K
Aliment Pharmacol Ther; 2015 Nov; 42(9):1051-63. PubMed ID: 26304302
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Complications of Liver Disease.
Acharya C; Bajaj JS
Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
[TBL] [Abstract][Full Text] [Related]
20. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]